Single nucleotide polymorphisms: early diagnosis and risk assessment in genitourinary malignancy (Q36469802)

14 August 2017

1 reference

title

Single nucleotide polymorphisms: early diagnosis and risk assessment in genitourinary malignancy (English)

1 reference

single-nucleotide polymorphism

14 August 2017

main subject

1 reference

1

Adam S Kibel

1 reference

14 August 2017

language of work or name

1 reference

1 May 2006

1 reference

14 August 2017

1 reference

14 August 2017

volume

24

1 reference

14 August 2017

issue

3

1 reference

14 August 2017

page(s)

224-230

1 reference

The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

The CAG repeat within the androgen receptor gene and its relationship to prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

RESPONSE: re: modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Alternatively spliced forms of cyclin D1 modulate entry into the cell cycle in an inverse manner.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Increased risk of prostate cancer associated with AA genotype of cyclin D1 gene A870G polymorphism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Association of the cyclin D1 A870G polymorphism with advanced colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Association of cyclin D1 polymorphism with increased susceptibility to oral squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

7 January 2021

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Removal of the financial barrier to health care: does it impact on prostate cancer at presentation and survival? A comparative study between black and white men in a Veterans Affairs system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Family history and the risk of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Familial prostate cancer studies in Utah

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Tobacco smoke inhalation pattern, tobacco type, and bladder cancer in Spain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Fruit and vegetable intake and incidence of bladder cancer in a male prospective cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Fluid intake and the risk of bladder cancer in men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Vitamin A supplements, fried foods, fat and urothelial cancer. A case-referent study in Stockholm in 1985-87.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Management of the postpubertal cryptorchid testis: a statistical review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Male genitourinary abnormalities and maternal diethylstilbestrol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Oral Contraceptives and Birth Defects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Prediction of post-radical prostatectomy pathological outcome for stage T1c prostate cancer with percent free prostate specific antigen: a prospective multicenter clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

A catalog of prostate cancer nomograms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Pretreatment nomogram for predicting freedom from recurrence after permanent prostate brachytherapy in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

A POSTOPERATIVE PROGNOSTIC NOMOGRAM PREDICTING RECURRENCE FOR PATIENTS WITH CONVENTIONAL CLEAR CELL RENAL CELL CARCINOMA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Multiplex Biomarker Approach for Determining Risk of Prostate-Specific Antigen-Defined Recurrence of Prostate Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Preoperative p27 status is an independent predictor of prostate specific antigen failure following radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Gene expression correlates of clinical prostate cancer behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

A molecular signature of metastasis in primary solid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Serum proteomic patterns for detection of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Genetic background is an important determinant of metastatic potential.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Gene expression profiling predicts clinical outcome of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

The V109G polymorphism of the p27 gene CDKN1B indicates a worse outcome in node-negative breast cancer patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Prospective study of sex hormone levels and risk of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

An allele-specific polymerase chain reaction method for the determination of the D85Y polymorphism in the human UDP-glucuronosyltransferase 2B15 gene in a case-control study of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Re: Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Isolation and characterization of UGT2B15(Y85): a UDP glucuronosyltransferase encoded by a polymorphic gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Naturally occurring human glutathione S-transferase GSTP1-1 isoforms with isoleucine and valine in position 104 differ in enzymic properties.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Functional significance of different human CYP1A1 genotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Genetic polymorphisms in cytochrome P450 (CYP) 1A1, CYP1A2, CYP2E1, glutathione S-transferase (GST) M1 and GSTT1 and susceptibility to prostate cancer in the Japanese population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Genetic Linkage of Lung Cancer-Associated MspI Polymorphisms with Amino Acid Replacement in the Heme Binding Region of the Human Cytochrome P450IA1 Gene1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Genetic polymorphism in the 5'-flanking region of human CYP1A2 gene: effect on the CYP1A2 inducibility in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Genetic Polymorphisms in the 5′-Flanking Region Change Transcriptional Regulation of the Human Cytochrome P450IIE1 Gene1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Combined genetic polymorphism and risk for development of lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Relationship of phenol sulfotransferase activity (SULT1A1) genotype to sulfotransferase phenotype in platelet cytosol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Characterization of human liver thermostable phenol sulfotransferase (SULT1A1) allozymes with 3,3',5-triiodothyronine as the substrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Phenol sulphotransferase SULT1A1*1 genotype is associated with reduced risk of colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Phenol sulphotransferase SULT1A1 polymorphism in prostate cancer: lack of association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Relationship between glutathione S-transferase M1, P1 and T1 polymorphisms and early onset prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Polymorphisms of glutathione-S-transferase genes (GSTP1, GSTM1 and GSTT1) and prostate-cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Glutathione S-transferases as risk factors in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Glutathione transferase isozyme genotypes in patients with prostate and bladder carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Glutathione-S-transferase M1, M3, T1 and P1 polymorphisms and susceptibility to non-small-cell lung cancer subtypes and hamartomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Polymorphisms in NAT2, CYP2D6, CYP2C19 and GSTP1 and their association with prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Assessing the probability that a positive report is false: an approach for molecular epidemiology studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Dietary calcium, vitamin D, VDR genotypes and colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Polymorphisms in the vitamin D receptor gene, ultraviolet radiation, and susceptibility to prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Overdiagnosis Due to Prostate-Specific Antigen Screening: Lessons From U.S. Prostate Cancer Incidence Trends

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

Incidental renal tumors: casting doubt on the efficacy of early intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.019

10.1016/J.UROLONC.2005.11.019

7 January 2021

Identifiers

DOI

1 reference

14 August 2017

1 reference